Role of chronic inflammation in cancers of the gastrointestinal system and the liver: where we are now.
Storr Liver Unit, Westmead Millennium Institute, the University of Sydney and Westmead Hospital, Westmead, NSW 2145, Australia. Electronic address: liang.qiao@sydney.edu.au.
Liang
L
Qiao
Hepatopancreatobiliary Surgery Institute of Gansu Province, Department of Surgery II, the First Hospital of Lanzhou University, Clinical Medical College Cancer Center of Lanzhou University, Lanzhou 730000, Gansu Province, China. Electronic address: lxdr21@sohu.com.
Xun
X
Li
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002471:Cell Transformation, Neoplastic / Q000276:immunology / Q000378:metabolism; D002908:Chronic Disease; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology / Q000378:metabolism; D006801:Humans; D007249:Inflammation / Q000150:complications* / Q000188:drug therapy / Q000276:immunology / Q000378:metabolism; D018836:Inflammation Mediators / Q000378:metabolism; D008113:Liver Neoplasms / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology / Q000378:metabolism; D011379:Prognosis; D012307:Risk Factors; D015398:Signal Transduction
D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D018836:Inflammation Mediators